Study of TNF-Antagonism in the Metabolic Syndrome (II)
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study will investigate whether etanercept will result in improved inflammatory indices,
glucose tolerance and endothelial function in patients with the metabolic syndrome.